[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tags-groups":3,"chains-groupcat":4,"experts-list":5,"experts-coverage":41},[],[],{"list":6,"total":39,"page":39,"pageSize":40,"totalPages":39},[7],{"id":8,"name":9,"orgName":10,"school":11,"gender":12,"title":13,"degree":14,"honor":14,"position":14,"researchDirection":15,"intro":16,"province":17,"completeness":18,"avatarAuthorized":19,"sourceUrl":20,"nameValid":21,"tags":22,"tagNames":38},"7d4f9471-693c-419b-81b1-649ca91168dc","刘浩文","西安交通大学生命科学与技术学院","西安交通大学","男","副教授",null,"1）突触前囊泡分泌的分子调控机制，2）突触后受体分布的调节机制及突触后反馈调节突触前机制，3）突触传递异质性机制及神经退行性疾病（帕金森病、精神分裂症、阿尔兹海默症等）的病理机制。实验室拥有电生理（膜片钳记录、钙成像）、电化学（微碳纤电极细胞\u002F脑片\u002Fin vivo水平的实时记录、微透析-HPLC分析）、生物成像（confocal、TIRF、two photon、电镜等）、光遗传、行为学及分子生化等特色技术手段，在囊泡分泌及突触传递分子调控机制方面取得一系列突破性研究进展。在国际权威学术期刊发表研究（SCI）论文22篇；其中，以第一作者在 eLife (2025,2019), Cell Rep (2021,2019,2018), Nat Commun (2023), PNAS (2021), J Cell Biol (2023, 2021), PLOS Genet (2022), J Neurosci (2018)等期刊发表高水平论文11篇。","【产业方向】生物医药","陕西",59,false,"https:\u002F\u002Fgr.xjtu.edu.cn\u002Fhwliu\u002Fzh_CN\u002Findex.htm",true,[23,26,29,32,35],{"code":24,"name":25},"CH-10","生物医药",{"code":27,"name":28},"CH-28","交通",{"code":30,"name":31},"GB-27","医药制造业",{"code":33,"name":34},"GB-73","研究和试验发展",{"code":36,"name":37},"SEI-04","生物产业",[25,28,31,34,37],1,30,{"schools":42},297]